Drugmakers to FDA: Can you speed it up? / by Scott A.

CANDIS EDWARDS: The FDA’s lack of resources is causing a backlog in generic drug approvals.

CANDIS EDWARDS: The FDA’s lack of resources is causing a backlog in generic drug approvals.

A deep backlog at the U.S. Food and Drug Administration is delaying approvals for thousands of generic drugs, including roughly 100 applications posted by a Long Island drugmaker.The FDA is sorting through a long list of approval requests, with thousands of medications that could save health care providers millions of dollars – not to mention save lives – stuck in the regulatory pipeline. There were 3,400 applications awaiting review in October 2012, according to the FDA, and as of this month, the administration had only whittled that down to 2,700.

Source: http://amneal.com/wp-content/uploads/2014/...